Wu A - Search Results

1

The miR-185/PAK6 axis predicts therapy response and regulates survival of drug-resistant leukemic stem cells in CML.

Lin H, Rothe K, Chen M, Wu A, Babaian A, Yen R, Zeng J, Ruschmann J, Petriv OI, O'Neill K, Maetzig T, Knapp DJHF, Nakamichi N, Brinkman R, Birol I, Forrest DL, Hansen C, Humphries RK, Eaves CJ, Jiang X. Lin H, et al. Among authors: wu a. Blood. 2020 Jul 30;136(5):596-609. doi: 10.1182/blood.2019003636. Blood. 2020. PMID: 32270193 Free PMC article.

2

p21-Activated kinases as promising therapeutic targets in hematological malignancies.

Wu A, Jiang X. Wu A, et al. Leukemia. 2022 Feb;36(2):315-326. doi: 10.1038/s41375-021-01451-7. Epub 2021 Oct 25. Leukemia. 2022. PMID: 34697424 Review.

3

Multiple gene knockdown strategies for investigating the properties of human leukemia stem cells and exploring new therapies.

Wu A, Ansari AS, Uludaǧ H, Jiang X. Wu A, et al. Methods Cell Biol. 2022;171:1-22. doi: 10.1016/bs.mcb.2022.04.002. Epub 2022 Jun 30. Methods Cell Biol. 2022. PMID: 35953195

4

Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial.

Yen R, Grasedieck S, Wu A, Lin H, Su J, Rothe K, Nakamoto H, Forrest DL, Eaves CJ, Jiang X. Yen R, et al. Among authors: wu a. Leukemia. 2022 Oct;36(10):2443-2452. doi: 10.1038/s41375-022-01680-4. Epub 2022 Aug 23. Leukemia. 2022. PMID: 35999259 Clinical Trial.

5

The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid Leukemia.

Wu A, Turner KA, Woolfson A, Jiang X. Wu A, et al. Pharmaceutics. 2023 Mar 16;15(3):958. doi: 10.3390/pharmaceutics15030958. Pharmaceutics. 2023. PMID: 36986819 Free PMC article. Review.

6

Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosis.

Wu A, Yen R, Grasedieck S, Lin H, Nakamoto H, Forrest DL, Eaves CJ, Jiang X. Wu A, et al. Leukemia. 2023 Dec;37(12):2426-2435. doi: 10.1038/s41375-023-02062-0. Epub 2023 Oct 17. Leukemia. 2023. PMID: 37848633

7

Clinical Insights into Structure, Regulation, and Targeting of ABL Kinases in Human Leukemia.

Wu A, Liu X, Fruhstorfer C, Jiang X. Wu A, et al. Int J Mol Sci. 2024 Mar 14;25(6):3307. doi: 10.3390/ijms25063307. Int J Mol Sci. 2024. PMID: 38542279 Free PMC article.

8

Bibliometrics analysis and knowledge mapping of pertussis vaccine research: trends from 1994 to 2023.

Tan C, Xiao Y, Chen S, Liu T, Zhou J, Zhang S, Hu Y, Zhou J, She Z, Tian B, Wu A, Li C. Tan C, et al. Among authors: wu a. Infection. 2024 Oct 17. doi: 10.1007/s15010-024-02414-7. Online ahead of print. Infection. 2024. PMID: 39417957

9

Suspended Tissue Open Microfluidic Patterning (STOMP).

Haack AJ, Brown LG, Goldstein AJ, Mulimani P, Berthier J, Viswanathan AR, Kopyeva I, Whitten JM, Lin A, Nguyen SH, Leahy TP, Bouker EE, Padgett RM, Mazzawi NA, Tokihiro JC, Bretherton RC, Wu A, Tapscott SJ, DeForest CA, Popowics TE, Berthier E, Sniadecki NJ, Theberge AB. Haack AJ, et al. Among authors: wu a. bioRxiv [Preprint]. 2024 Oct 7:2024.10.04.616662. doi: 10.1101/2024.10.04.616662. bioRxiv. 2024. PMID: 39416011 Free PMC article. Preprint.

10

Application of life history theory to explain the association between childhood maltreatment and adulthood sleep problems in Chinese men with drug abuse: multiple mediating roles of emotion regulation, future-oriented coping, and anxiety.

Feng C, Wu AMS, Chen YP, Xing Y, Zhai R, Zhang XY. Feng C, et al. Among authors: wu ams. Eur J Psychotraumatol. 2024;15(1):2411881. doi: 10.1080/20008066.2024.2411881. Epub 2024 Oct 17. Eur J Psychotraumatol. 2024. PMID: 39415717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,143 results

Search Page